vs
Digimarc CORP（DMRC）与Voyager Therapeutics, Inc.（VYGR）财务数据对比。点击上方公司名可切换其他公司
Voyager Therapeutics, Inc.的季度营收约是Digimarc CORP的1.7倍（$15.3M vs $8.9M），Voyager Therapeutics, Inc.同比增速更快（144.3% vs 2.9%），Digimarc CORP自由现金流更多（$895.0K vs $-135.1M），过去两年Digimarc CORP的营收复合增速更高（-5.3% vs -11.4%）
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
Voyager Therapeutics是一家临床阶段生物技术企业，专注于开发腺相关病毒基因疗法，用于治疗帕金森病、肌萎缩侧索硬化症等严重神经系统疾病及罕见中枢神经系统单基因遗传病，主要面向美国市场，与全球药企合作推进管线研发。
DMRC vs VYGR — 直观对比
营收规模更大
VYGR
是对方的1.7倍
$8.9M
营收增速更快
VYGR
高出141.4%
2.9%
自由现金流更多
DMRC
多$136.0M
$-135.1M
两年增速更快
DMRC
近两年复合增速
-11.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.9M | $15.3M |
| 净利润 | $-4.2M | — |
| 毛利率 | 63.5% | — |
| 营业利润率 | -48.2% | — |
| 净利率 | -47.2% | — |
| 营收同比 | 2.9% | 144.3% |
| 净利润同比 | 51.4% | 20.5% |
| 每股收益（稀释后） | $-0.18 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DMRCVYGR
| Q4 25 | $8.9M | $15.3M | ||
| Q3 25 | $7.6M | $13.4M | ||
| Q2 25 | $8.0M | $5.2M | ||
| Q1 25 | $9.4M | $6.5M | ||
| Q4 24 | $8.7M | $6.3M | ||
| Q3 24 | $9.4M | $24.6M | ||
| Q2 24 | $10.4M | $29.6M | ||
| Q1 24 | $9.9M | $19.5M |
净利润DMRCVYGR
| Q4 25 | $-4.2M | — | ||
| Q3 25 | $-8.2M | $-27.9M | ||
| Q2 25 | $-8.2M | $-33.4M | ||
| Q1 25 | $-11.7M | $-31.0M | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-10.8M | $-9.0M | ||
| Q2 24 | $-9.3M | $-10.1M | ||
| Q1 24 | $-10.3M | $-11.3M |
毛利率DMRCVYGR
| Q4 25 | 63.5% | — | ||
| Q3 25 | 58.3% | — | ||
| Q2 25 | 58.8% | — | ||
| Q1 25 | 65.0% | — | ||
| Q4 24 | 60.8% | — | ||
| Q3 24 | 62.4% | — | ||
| Q2 24 | 66.1% | — | ||
| Q1 24 | 62.5% | — |
营业利润率DMRCVYGR
| Q4 25 | -48.2% | — | ||
| Q3 25 | -109.7% | -228.9% | ||
| Q2 25 | -105.2% | -704.3% | ||
| Q1 25 | -128.9% | -536.0% | ||
| Q4 24 | -105.1% | — | ||
| Q3 24 | -120.4% | -56.0% | ||
| Q2 24 | -96.2% | -50.8% | ||
| Q1 24 | -109.2% | -82.9% |
净利率DMRCVYGR
| Q4 25 | -47.2% | — | ||
| Q3 25 | -106.9% | -208.7% | ||
| Q2 25 | -102.6% | -642.0% | ||
| Q1 25 | -125.2% | -479.2% | ||
| Q4 24 | -99.9% | — | ||
| Q3 24 | -113.9% | -36.7% | ||
| Q2 24 | -89.3% | -34.3% | ||
| Q1 24 | -104.0% | -58.1% |
每股收益（稀释后）DMRCVYGR
| Q4 25 | $-0.18 | — | ||
| Q3 25 | $-0.38 | $-0.47 | ||
| Q2 25 | $-0.38 | $-0.57 | ||
| Q1 25 | $-0.55 | $-0.53 | ||
| Q4 24 | $-0.40 | — | ||
| Q3 24 | $-0.50 | $-0.16 | ||
| Q2 24 | $-0.43 | $-0.18 | ||
| Q1 24 | $-0.50 | $-0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | $196.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $40.2M | $196.1M |
| 总资产 | $53.0M | $252.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DMRCVYGR
| Q4 25 | $12.9M | $196.4M | ||
| Q3 25 | $12.6M | $208.9M | ||
| Q2 25 | $16.1M | $215.6M | ||
| Q1 25 | $21.6M | $236.0M | ||
| Q4 24 | $28.7M | $266.7M | ||
| Q3 24 | $33.7M | $345.4M | ||
| Q2 24 | $41.5M | $371.0M | ||
| Q1 24 | $48.9M | $399.6M |
股东权益DMRCVYGR
| Q4 25 | $40.2M | $196.1M | ||
| Q3 25 | $41.4M | $219.8M | ||
| Q2 25 | $46.5M | $243.9M | ||
| Q1 25 | $50.0M | $272.7M | ||
| Q4 24 | $61.4M | $299.8M | ||
| Q3 24 | $70.2M | $330.3M | ||
| Q2 24 | $77.2M | $335.4M | ||
| Q1 24 | $84.5M | $340.9M |
总资产DMRCVYGR
| Q4 25 | $53.0M | $252.3M | ||
| Q3 25 | $55.4M | $288.3M | ||
| Q2 25 | $60.7M | $322.1M | ||
| Q1 25 | $66.5M | $353.2M | ||
| Q4 24 | $75.8M | $393.1M | ||
| Q3 24 | $85.0M | $426.0M | ||
| Q2 24 | $93.4M | $436.2M | ||
| Q1 24 | $99.7M | $469.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $991.0K | $-132.5M |
| 自由现金流经营现金流 - 资本支出 | $895.0K | $-135.1M |
| 自由现金流率自由现金流/营收 | 10.0% | -880.7% |
| 资本支出强度资本支出/营收 | 1.1% | 16.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.3M | $-239.2M |
8季度趋势，按日历期对齐
经营现金流DMRCVYGR
| Q4 25 | $991.0K | $-132.5M | ||
| Q3 25 | $-2.6M | $-31.0M | ||
| Q2 25 | $-4.7M | $-33.3M | ||
| Q1 25 | $-5.5M | $-37.9M | ||
| Q4 24 | $-4.2M | $-15.3M | ||
| Q3 24 | $-7.1M | $-28.0M | ||
| Q2 24 | $-6.8M | $-31.6M | ||
| Q1 24 | $-8.4M | $58.8M |
自由现金流DMRCVYGR
| Q4 25 | $895.0K | $-135.1M | ||
| Q3 25 | $-2.8M | $-31.3M | ||
| Q2 25 | $-4.9M | $-34.4M | ||
| Q1 25 | $-5.5M | $-38.6M | ||
| Q4 24 | $-4.2M | $-18.8M | ||
| Q3 24 | $-7.2M | $-28.2M | ||
| Q2 24 | $-6.9M | $-32.5M | ||
| Q1 24 | $-8.5M | $56.6M |
自由现金流率DMRCVYGR
| Q4 25 | 10.0% | -880.7% | ||
| Q3 25 | -36.9% | -233.9% | ||
| Q2 25 | -61.0% | -660.9% | ||
| Q1 25 | -59.1% | -595.6% | ||
| Q4 24 | -49.1% | -300.0% | ||
| Q3 24 | -75.7% | -114.6% | ||
| Q2 24 | -66.1% | -110.0% | ||
| Q1 24 | -85.8% | 290.2% |
资本支出强度DMRCVYGR
| Q4 25 | 1.1% | 16.9% | ||
| Q3 25 | 2.9% | 1.5% | ||
| Q2 25 | 2.5% | 21.3% | ||
| Q1 25 | 0.6% | 10.2% | ||
| Q4 24 | 0.2% | 56.1% | ||
| Q3 24 | 0.7% | 1.0% | ||
| Q2 24 | 0.3% | 3.3% | ||
| Q1 24 | 1.1% | 11.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
VYGR
暂无分部数据
